Temozolomide Feasibility Calculator
for elderly patients with glioblastoma
F Putz et al. (2014)
* Probability of successful administration of concurrent chemotherapy with a cumulative dose of temozolomide >2655 mg/m²
Note:
Active inflammation can cause thrombocytosis without increased tolerability of temozolomide
Female? :
Age (≥ 65 years) :
Pretreatment platelet count (10³ cells/µl) :
Probability*
%